Caricamento...
Existing agents, novel agents, or transplantation for high-risk MDS
The decision algorithm for treatment of advanced myelodysplastic syndrome (MDS) (intermediate- to very high-risk by the revised International Prognostic Scoring System [IPSS-R]) is complex. Often, the appropriate choice is unknown and not currently addressed by available clinical evidence. Although...
Salvato in:
| Pubblicato in: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society of Hematology
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7727538/ https://ncbi.nlm.nih.gov/pubmed/33275695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2020000125 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|